title: Rifaximin systemic absorption in patients with ulcerative colitis.
authors.forename: F
authors.initials: F
authors.lastname: Rizzello
authors.forename: P
authors.initials: P
authors.lastname: Gionchetti
authors.forename: A
authors.initials: A
authors.lastname: Venturi
authors.forename: M
authors.initials: M
authors.lastname: Ferretti
authors.forename: S
authors.initials: S
authors.lastname: Peruzzo
authors.forename: X
authors.initials: X
authors.lastname: Raspanti
authors.forename: M
authors.initials: M
authors.lastname: Picard
authors.forename: N
authors.initials: N
authors.lastname: Canova
authors.forename: E
authors.initials: E
authors.lastname: Palazzini
authors.forename: M
authors.initials: M
authors.lastname: Campieri
mesh_terms: D000042:Absorption; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003093:Colitis, Ulcerative / Q000097:blood / Q000188:drug therapy / Q000378:metabolism* / Q000652:urine; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012294:Rifamycins / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use / Q000652:urine; D000078262:Rifaximin
chemical_list: D012294:Rifamycins; D000078262:Rifaximin